Discover 2,423 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,423
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
for
Prostate Cancer
Location: Baltimore MD, New York NY, Seattle WA
Sponsor: Prostate Cancer Clinical Trials Consortium
Sex: Male
Age: 18+
Code: NCT04995198
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Rockville MD, Baltimore MD, Richmond VA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase 3, Recruiting
Synbiotic Compound to Reduce Symptoms of Schizophrenia
for
Schizophrenia, Schizoaffective Disorder
Location: Batlimore MD
Sponsor: Sheppard Pratt Health System
Sex: All
Age: 18 - 65
Code: NCT04226898
Phase 2, Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Baltimore MD, The Bronx NY, New Haven CT, Columbus OH,
Sponsor: DynamiCure Biotechnology
Sex: All
Age: 18+
Code: NCT05785754
Phase 1, Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Washington D.C. DC, Annapolis MD, Baltimore MD,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
for
Hepatocellular Carcinoma, Biliary Tract Cancer
Location: Baltimore MD, Philadelphia PA, Pittsburgh PA,
Sponsor: Replimune Inc.
Sex: All
Age: 18+
Code: NCT05733598
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Washington D.C. DC, Hyattsville MD, Charlotte NC,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05894239
Phase 3, Recruiting
Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
for
Oropharyngeal Cancers, HPV, Tonsil Cancer,
Location: Washington D.C. DC, Clinton MD
Sponsor: Georgetown University
Sex: All
Age: 18+
Code: NCT06902623
Recruiting
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
for
Breast Reconstruction Surgery
Location: Baltimore MD, Philadelphia PA, New York NY,
Sponsor: W.L.Gore & Associates
Sex: Female
Age: 22+
Code: NCT06556654
Recruiting
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
for
Pancreatic Cyst
Location: Baltimore MD, New York NY, Garden City NY, New Haven CT,
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT03492151
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
for
Respiratory Insufficiency,
Location: Baltimore MD, Philadelphia PA, Norfolk VA,
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT05440851
Recruiting
Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
for
Pressure Ulcers Stage II, Pressure Ulcers Stage III,
Location: Washington D.C. DC, Baltimore MD, Pittsburgh PA,
Sponsor: ULURU Inc.
Sex: All
Age: 18 - 70+
Code: NCT05496296
Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Silver Spring MD, Baltimore MD, Hershey PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase 3, Recruiting
Optimal Pacing Rate for Cardiac Resynchronization Therapy
for
Atrial Fibrillation, Persistent
Location: Washington DC, Fairfax VA, Clinton MD
Sponsor: Medstar Health Research Institute
Sex: All
Age: 18 - 70+
Code: NCT06445439
Recruiting
A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumors That Are MTAP Deficient
Location: Fairfax VA, Baltimore MD, Pittsburgh PA, New Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06130553
Phase 1, Phase 2, Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Washington D.C. DC, Hanover MD, Annapolis MD,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase 3, Recruiting
TruGraf® Long-term Clinical Outcomes Study
for
Kidney Transplant Rejection
Location: Washington DC, Falls Church VA, Baltimore MD,
Sponsor: Transplant Genomics, Inc.
Sex: All
Age: 18+
Code: NCT04491552
Recruiting
Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
for
Radiation-Induced Xerostomia and Hyposalivation
Location: Baltimore MD, Philadelphia PA, New York NY,
Sponsor: RiboX Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06714253
Phase 1, Phase 2, Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue